María Ángeles Lobo-Acosta

MÁ

Statistics

Publications

Citations

186

H-Index

Active since

2019

Affiliations

Instituto de Investigación Marqués de Valdecilla(Current)

Hospital Universitario Virgen del Rocío

Universidad de Sevilla

Hospital Universitario Reina Sofía

Universitat Autònoma de Barcelona

María Ángeles Lobo-Acosta is an author at Instituto de Investigación Marqués de Valdecilla specializing in immunology, life sciences, and immunosuppressive therapy.

ORCID

Publications per year

2019–2022

Publications

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant <i>Escherichia coli</i> Bacteremic Urinary Tract Infections

Jesús Sojo-Dorado, Inmaculada López-Hernández, Clara Rosso-Fernández et al. · JAMA Network Open · 2022 · 87 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial

Aurora Páez-Vega, Belén Gutiérrez‐Gutiérrez, M.L. Agüera et al. · Clinical Infectious Diseases · 2021 · 68 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy

Víctor Sánchez‐Margalet, Antonio Barco-Sánchez, Teresa Vilariño‐García et al. · Translational Cancer Research · 2019 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial

Aurora Páez-Vega, Sara Cantisán, J.M. Vaquero et al. · BMJ Open · 2019 · 12 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–4 of 4